Heidelberg Pharma is trading at 2.35 as of the 5th of January 2025, a 2.49 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.35. Heidelberg Pharma has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 6th of November 2024 and ending today, the 5th of January 2025. Click here to learn more.
Although Heidelberg Pharma's alpha and beta are two of the key measurements used to evaluate Heidelberg Pharma's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Heidelberg Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run USA ETFs Now
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.